ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 폐암 수술 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년까지 CAGR 4.8%로 확대되어 64억 3,000만 달러로 성장할 것으로 예상됩니다. 예측기간 중 성장의 원동력은 세계 인구의 고령화, 비소세포폐암 증례 증가, 신흥 시장에서의 인지도의 향상, 로봇 수술 플랫폼의 확대, 암 치료에 대한 투자의 확대라고 예상됩니다. 이 기간의 주요 동향으로는 로봇 지원 흉부 수술, 수술에서 증강현실의 응용, 수술 시뮬레이션을 위한 3D 프린팅 사용, 수술 계획을 위한 인공지능, 스마트 수술 기구 개발 등이 있습니다.
폐암의 이환율 상승은 향후 폐암 수술 시장의 성장을 가속할 것으로 예측됩니다. 폐암은 한쪽 또는 양쪽 폐에 비정상적인 세포가 무질서하게 증식하여 정상적인 폐 기능을 파괴할 수 있습니다. 폐암 환자 증가는 대기 오염과 미세 미립자 물질에 장기간 노출되는 것과 관련이 있습니다. 이러한 미립자는 폐의 깊이까지 침투하여 염증, 세포 손상, 돌연변이를 일으켜 암으로 이어질 수 있기 때문입니다. 폐암 수술은 악성 종양이 퍼지거나 악화되기 전에 조기에 절제할 수 있도록 함으로써 폐암과 관련된 사망률의 감소에 중요한 역할을 하고 있습니다. 예를 들어, 2025년 6월 미국 연방 정부 기관인 질병 대책 예방 센터는 2022년에 새롭게 진단된 21만 8,893명의 증례에 이어, 2023년에는 미국에서 13만 1,584명이 폐암으로 사망한다고 보고했습니다. 따라서 폐암 발생 건수 증가가 폐암 수술 시장에 박차를 가하고 있습니다.
폐암 수술 시장의 주요 기업은 수술 정밀도 향상, 회복 기간 단축, 환자 예후 향상을 위해 로봇 지원 수술과 같은 혁신적인 기술 개발에 주력하고 있습니다. 로봇 지원 수술은 외과의사가 제어하는 로봇 시스템에서 수행되는 저침습 수술을 포함하여 정확도 향상, 합병증 감소, 더 나은 회복 결과를 제공합니다. 예를 들어 2025년 3월 미국 의료기기 및 기술기업인 Johnson & Johnson MedTech은 미국 510(k)에 기반한 로봇 지원 기관지경 플랫폼 'MONARCH QUEST'의 약사 승인을 발표했습니다. 이 플랫폼은 도달하기 어려운 작은 폐 결절에 도달하기 위한 도달 범위와 안정성을 향상시키고 폐암의 조기 진단에 기여합니다. 첨단 조작성과 이미징 기술의 통합은 환자의 불편함을 줄이면서 보다 정확한 생검을 가능하게 합니다. 이 플랫폼은 수술 능력을 확장하고 워크플로우를 간소화하도록 설계되었으며, 광범위한 기관지경 수술에서 더 높은 임상적 신뢰성과 일관성을 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 폐암 수술 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 폐암 수술 시장 : 성장률 분석
세계의 폐암 수술 시장 실적 : 규모와 성장, 2019-2024
세계의 폐암 수술 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 폐암 수술 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 폐암 수술 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
개흉술
저침습 수술
세계의 폐암 수술 시장 : 수술별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
폐엽절제술
분엽절제술
폐 절제술
슬리브 절제술
확대제술
세계의 폐암 수술 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
흉강경
종격경
기관지경
로봇 지원 흉부 수술 시스템
외과용 스테이플러
수술용 에너지 기구
첨단 에너지 기구
고급 바이폴라 기구
초음파 기구
기타 제품
세계의 폐암 수술 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
직접 입찰
소매 매출
온라인 판매
기타 채널
세계의 폐암 수술 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
외래 및 외과 센터
학술연구기관
전문 암 케어 센터
기타 최종 사용자
세계의 폐암 수술 시장 : 개흉술 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
폐엽절제술
폐절제술
분엽절제술
쐐기 절제
세계의 폐암 수술 시장 : 저침습 수술 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
비디오 보조 흉강경 수술(VATS)
로봇 지원 수술
제7장 지역별/국가별 분석
세계의 폐암 수술 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 폐암 수술 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
폐암 수술 시장 : 경쟁 구도
폐암 수술 시장 : 기업 프로파일
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthcare GmbH : 개요, 제품 및 서비스, 전략 및 재무 분석
Fujifilm Holdings Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
GE Healthcare Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
B. Braun Melsungen AG
Olympus Corporation
Intuitive Surgical Inc.
Teleflex Incorporated
Varian Medical Systems Inc.
Karl Storz SE
Lepu Medical Technology(Beijing) Co. Ltd.
Ambu A/S
Accuray Incorporated
KLS Martin Group
Richard Wolf GmbH
Ethicon Inc.
AngioDynamics Inc.
Ackermann Instrument GmbH
Scanlan International Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
폐암 수술 시장(2029년) : 새로운 기회를 제공하는 국가
폐암 수술 시장(2029년) : 새로운 기회를 제공하는 부문
폐암 수술 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Lung cancer surgery is a procedure aimed at removing cancerous tissue from the lungs. It is generally performed when the cancer is localized within the lung and has not extensively spread. The primary objective is to fully excise the tumor along with affected lung tissue to halt cancer progression or recurrence.
The main categories of lung cancer surgery include thoracotomy and minimally invasive techniques. Thoracotomy involves making an incision in the chest wall to access the lungs or other chest organs. Procedures under this umbrella include lobectomy, segmentectomy, pneumonectomy, sleeve resection, and extended resection. These surgeries utilize various tools and technologies such as thoracoscopes, mediastinoscopes, bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers, surgical energy devices including advanced bipolar and ultrasonic instruments-and more. These products are distributed through channels like direct tenders, retail sales, and online platforms. Key end users consist of hospitals, ambulatory surgical centers, academic and research institutions, specialty cancer care centers, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The lung cancer surgery market research report is one of a series of new reports from The Business Research Company that provides lung cancer surgery market statistics, including lung cancer surgery industry global market size, regional shares, competitors with a lung cancer surgery market share, detailed lung cancer surgery market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer surgery industry. The lung cancer surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lung cancer surgery market size has grown strongly in recent years. It will grow from $5.07 billion in 2024 to $5.33 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. Growth during the historic period can be attributed to the high prevalence of smoking, increasing incidence of lung cancer, expansion of hospital infrastructure, broader insurance coverage, and enhanced expertise among surgeons.
The lung cancer surgery market size is expected to see steady growth in the next few years. It will grow to $6.43 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. Growth in the forecast period is expected to be driven by the aging global population, an increase in non-small cell lung cancer cases, rising awareness in emerging markets, the expansion of robotic surgery platforms, and greater investment in cancer care. Key trends during this period include robotic-assisted thoracic surgery, the application of augmented reality in surgery, the use of 3D printing for surgical simulation, artificial intelligence for surgical planning, and the development of smart surgical instruments.
The rising incidence of lung cancer is expected to drive the growth of the lung cancer surgery market in the future. Lung cancer involves the uncontrolled proliferation of abnormal cells in one or both lungs, which can disrupt normal lung function. The increase in lung cancer cases is linked to prolonged exposure to air pollution and fine particulate matter, as these tiny particles penetrate deep into the lungs, causing inflammation, cellular damage, and mutations that may lead to cancer. Lung cancer surgery plays a crucial role in reducing lung cancer-related mortality by enabling early removal of malignant tumors before they spread or worsen. For example, in June 2025, the Centers for Disease Control and Prevention, a US federal agency, reported that lung cancer caused 131,584 deaths in the United States in 2023, following 218,893 newly diagnosed cases in 2022. Therefore, the rising occurrence of lung cancer is fueling the lung cancer surgery market.
Leading companies in the lung cancer surgery market are focusing on developing innovative technologies like robotic-assisted surgeries to improve surgical accuracy, shorten recovery periods, and enhance patient outcomes. Robotic-assisted surgeries involve minimally invasive procedures performed with robotic systems controlled by surgeons, offering increased precision, fewer complications, and better recovery results. For instance, in March 2025, Johnson & Johnson MedTech, a US medical device and technology company, announced regulatory clearance of the MONARCH QUEST robotic-assisted bronchoscopy platform under U.S. 510(k). This platform provides improved reach and stability to access small, hard-to-reach lung nodules, aiding earlier diagnosis of lung cancer. Its advanced maneuverability and integration with imaging technologies allow for more precise biopsies while reducing patient discomfort. Designed to expand procedural capabilities and streamline workflows, the platform supports greater clinical confidence and consistency across a broad range of bronchoscopic procedures.
In June 2023, AstraZeneca Pharma India Ltd., an India-based pharmaceutical manufacturer, partnered with Rajiv Gandhi Cancer Institute and Research Center to enhance lung cancer diagnostic capabilities by establishing a Center of Excellence focused on advancing early and accurate testing. This collaboration seeks to improve patient outcomes by facilitating timely diagnosis, increasing access to advanced testing technologies, and supporting personalized treatment strategies for lung cancer. Rajiv Gandhi Cancer Institute and Research Center, based in India, provides thoracic surgery services, including minimally invasive methods such as video-assisted thoracoscopic surgery (VATS) and robotic surgery for lung cancer.
Major players in the lung cancer surgery market are Johnson & Johnson, Medtronic plc, Siemens Healthcare GmbH, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Teleflex Incorporated, Varian Medical Systems Inc., Karl Storz SE, Lepu Medical Technology (Beijing) Co. Ltd., Ambu A/S, Accuray Incorporated, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc., AngioDynamics Inc., Ackermann Instrument GmbH, Scanlan International Inc., Sontec Instruments Inc., Covidien LLC.
North America was the largest region in the lung cancer surgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lung cancer surgery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the lung cancer surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lung cancer surgery market consists of revenues earned by entities providing services such as preoperative and postoperative care, follow-up and monitoring and surgical procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The lung cancer surgery market includes sales of products such as surgical instruments, stapling devices, electrosurgical units, thoracoscopes, and robotic surgical systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lung Cancer Surgery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lung cancer surgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lung cancer surgery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lung cancer surgery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Thoracotomy; Minimally Invasive Surgeries
2) By Procedure: Lobectomy; Segmentectomy; Pneumonectomy; Sleeve Resection; Extended Reserction
3) By Product: Thoracoscopes; Mediastinoscopes; Bronchoscopes; Robotic-Assistes Thoracic Surgery Systems; Surgical Staplers; Surgical Energy Instruments; Advanced Energy Instruments; Advanced Bipolar Instruments; Ultrasonic Instruments
4) By Distribution Channels: Direct Tender; Retail Sales; Online Sales; Other Channels
5) By End User: Hospitals; Ambulatory And Surgical Centres; Academic And Research Institutes; Specialiaty Cancer Care Centre; Other End Users
Subsegments:
1) By Thoracotomy: Lobectomy; Pneumonectomy; Segmentectomy; Wedge Resection
2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS); Robotic-Assisted Surgery
Companies Mentioned: Johnson & Johnson; Medtronic plc; Siemens Healthcare GmbH; Fujifilm Holdings Corporation; GE Healthcare Technologies Inc.; B. Braun Melsungen AG; Olympus Corporation; Intuitive Surgical Inc.; Teleflex Incorporated; Varian Medical Systems Inc.; Karl Storz SE; Lepu Medical Technology (Beijing) Co. Ltd.; Ambu A/S; Accuray Incorporated; KLS Martin Group; Richard Wolf GmbH; Ethicon Inc.; AngioDynamics Inc.; Ackermann Instrument GmbH; Scanlan International Inc.; Sontec Instruments Inc.; Covidien LLC
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lung Cancer Surgery Market Characteristics
3. Lung Cancer Surgery Market Trends And Strategies
4. Lung Cancer Surgery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Lung Cancer Surgery Growth Analysis And Strategic Analysis Framework
5.1. Global Lung Cancer Surgery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lung Cancer Surgery Market Growth Rate Analysis
5.4. Global Lung Cancer Surgery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lung Cancer Surgery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lung Cancer Surgery Total Addressable Market (TAM)
6. Lung Cancer Surgery Market Segmentation
6.1. Global Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thoracotomy
Minimally Invasive Surgeries
6.2. Global Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lobectomy
Segmentectomy
Pneumonectomy
Sleeve Resection
Extended Reserction
6.3. Global Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thoracoscopes
Mediastinoscopes
Bronchoscopes
Robotic-Assistes Thoracic Surgery Systems
Surgical Staplers
Surgical Energy Instruments
Advanced Energy Instruments
Advanced Bipolar Instruments
Ultrasonic Instruments
Other Products
6.4. Global Lung Cancer Surgery Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Direct Tender
Retail Sales
Online Sales
Other Channels
6.5. Global Lung Cancer Surgery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory And Surgical Centres
Academic And Research Institutes
Specialiaty Cancer Care Centre
Other End Users
6.6. Global Lung Cancer Surgery Market, Sub-Segmentation Of Thoracotomy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lobectomy
Pneumonectomy
Segmentectomy
Wedge Resection
6.7. Global Lung Cancer Surgery Market, Sub-Segmentation Of Minimally Invasive Surgeries, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Video-Assisted Thoracoscopic Surgery (VATS)
Robotic-Assisted Surgery
7. Lung Cancer Surgery Market Regional And Country Analysis
7.1. Global Lung Cancer Surgery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lung Cancer Surgery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lung Cancer Surgery Market
8.1. Asia-Pacific Lung Cancer Surgery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lung Cancer Surgery Market
9.1. China Lung Cancer Surgery Market Overview
9.2. China Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lung Cancer Surgery Market
10.1. India Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lung Cancer Surgery Market
11.1. Japan Lung Cancer Surgery Market Overview
11.2. Japan Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lung Cancer Surgery Market
12.1. Australia Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lung Cancer Surgery Market
13.1. Indonesia Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lung Cancer Surgery Market
14.1. South Korea Lung Cancer Surgery Market Overview
14.2. South Korea Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lung Cancer Surgery Market
15.1. Western Europe Lung Cancer Surgery Market Overview
15.2. Western Europe Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lung Cancer Surgery Market
16.1. UK Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lung Cancer Surgery Market
17.1. Germany Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lung Cancer Surgery Market
18.1. France Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lung Cancer Surgery Market
19.1. Italy Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lung Cancer Surgery Market
20.1. Spain Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lung Cancer Surgery Market
21.1. Eastern Europe Lung Cancer Surgery Market Overview
21.2. Eastern Europe Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lung Cancer Surgery Market
22.1. Russia Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lung Cancer Surgery Market
23.1. North America Lung Cancer Surgery Market Overview
23.2. North America Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lung Cancer Surgery Market
24.1. USA Lung Cancer Surgery Market Overview
24.2. USA Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lung Cancer Surgery Market
25.1. Canada Lung Cancer Surgery Market Overview
25.2. Canada Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lung Cancer Surgery Market
26.1. South America Lung Cancer Surgery Market Overview
26.2. South America Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lung Cancer Surgery Market
27.1. Brazil Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lung Cancer Surgery Market
28.1. Middle East Lung Cancer Surgery Market Overview
28.2. Middle East Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lung Cancer Surgery Market
29.1. Africa Lung Cancer Surgery Market Overview
29.2. Africa Lung Cancer Surgery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Lung Cancer Surgery Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Lung Cancer Surgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lung Cancer Surgery Market Competitive Landscape And Company Profiles
30.1. Lung Cancer Surgery Market Competitive Landscape
30.2. Lung Cancer Surgery Market Company Profiles
30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Lung Cancer Surgery Market Other Major And Innovative Companies
31.1. B. Braun Melsungen AG
31.2. Olympus Corporation
31.3. Intuitive Surgical Inc.
31.4. Teleflex Incorporated
31.5. Varian Medical Systems Inc.
31.6. Karl Storz SE
31.7. Lepu Medical Technology (Beijing) Co. Ltd.
31.8. Ambu A/S
31.9. Accuray Incorporated
31.10. KLS Martin Group
31.11. Richard Wolf GmbH
31.12. Ethicon Inc.
31.13. AngioDynamics Inc.
31.14. Ackermann Instrument GmbH
31.15. Scanlan International Inc.
32. Global Lung Cancer Surgery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lung Cancer Surgery Market
34. Recent Developments In The Lung Cancer Surgery Market
35. Lung Cancer Surgery Market High Potential Countries, Segments and Strategies
35.1 Lung Cancer Surgery Market In 2029 - Countries Offering Most New Opportunities
35.2 Lung Cancer Surgery Market In 2029 - Segments Offering Most New Opportunities
35.3 Lung Cancer Surgery Market In 2029 - Growth Strategies
